BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34981775)

  • 1. The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
    Chalmers SA; Ayilam Ramachandran R; Garcia SJ; Der E; Herlitz L; Ampudia J; Chu D; Jordan N; Zhang T; Parodis I; Gunnarsson I; Ding H; Shen N; Petri M; Mok CC; Saxena R; Polu KR; Connelly S; Ng CT; Mohan C; Putterman C
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
    Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
    Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
    Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
    J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
    Rambaldi B; Kim HT; Arihara Y; Asano T; Reynolds C; Manter M; Halpern M; Weber A; Koreth J; Cutler C; Gooptu M; Nikiforow S; Ho VT; Antin JH; Romee R; Ampudia J; Ng C; Connelly S; Soiffer RJ; Ritz J
    Haematologica; 2022 Nov; 107(11):2617-2629. PubMed ID: 35484649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6.
    Te Riet J; Helenius J; Strohmeyer N; Cambi A; Figdor CG; Müller DJ
    J Cell Sci; 2014 Apr; 127(Pt 7):1595-606. PubMed ID: 24496453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic activated leukocyte cell adhesion molecule induces CD6
    Qian Q; Cui N; Huang B; Zhao Y; Liu Q; Hu M; Li B; Wang Q; Miao Q; You Z; Ma X; Tang R
    Front Immunol; 2022; 13():967944. PubMed ID: 36159854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
    Nair P; Melarkode R; Rajkumar D; Montero E
    Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
    Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
    J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1.
    da Glória VG; Martins de Araújo M; Mafalda Santos A; Leal R; de Almeida SF; Carmo AM; Moreira A
    J Immunol; 2014 Jul; 193(1):391-9. PubMed ID: 24890719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
    Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
    J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
    Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
    Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
    Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
    J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
    Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
    J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.
    Singer NG; Mitra R; Lialios F; Richardson BC; Marks RM; Pesando JM; Fox DA; Nickoloff BJ
    Immunol Lett; 1997 Jun; 58(1):9-14. PubMed ID: 9436462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology.
    Ding H; Lin C; Cai J; Guo Q; Dai M; Mohan C; Shen N
    Arthritis Res Ther; 2020 May; 22(1):122. PubMed ID: 32460901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
    Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
    Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis.
    Soliman SA; Stanley S; Vanarsa K; Ismail F; Mok CC; Mohan C
    Front Immunol; 2022; 13():910993. PubMed ID: 36091001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical validation of urine ALCAM ELISA as a test for lupus nephritis.
    Lei R; Thai N; Li Y; Petri M; Mohan C
    Expert Rev Mol Diagn; 2023; 23(8):729-738. PubMed ID: 37431809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.